Concepedia

Hajir Ibraheim

HI

12

Publications

668

Citations

11

H-Index

2019

Active since

Affiliations

Imperial College London(Current)

King's College London

Guy's and St Thomas' NHS Foundation Trust

University of Hull

University of Exeter

Hajir Ibraheim is an author at Imperial College London specializing in inflammation, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2019–2024

12

Publications

12

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

Hamzah Abu‐Sbeih, David M. Faleck, Biagio Ricciuti et al. · Journal of Clinical Oncology · 2019 · 188 citations · Full text

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 147 citations · Full text

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

James L. Alexander, Zhigang Liu, Diana Mūnoz Sandoval et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 64 citations · Full text

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

James L. Alexander, Benjamin H. Mullish, Nathan Danckert et al. · EBioMedicine · 2023 · 53 citations · Full text

Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

Neil Chanchlani, Simeng Lin, Desmond Chee et al. · Journal of Crohn s and Colitis · 2021 · 45 citations · Full text

Rows per page

1–5 of 12